2nd Quarter - Report

WILLIAMS AND JENSEN, PLLC for PFIZER

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; Medicare Part D; drug importation; and drug shortages. Drug pricing proposals. Medicare rebate reform, the 340B program, and proposals to impose "most favored nation" pricing on Medicare Part B and D. "Inflation Reduction Act of 2022" (PL 117-169). PASTEUR Act. Policies impacting post pandemic public health emergency Covid-19 vaccine reimbursement and distribution. Pharmacy benefit manager reform proposals.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
KARINA LYNCH Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs
MELINDA M MAXFIELD —
CHRISTOPHER E. WILCOX Regional Staff Asst & Staff Asst, Sen. Moynihan; LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings
DANIEL ZIEGLER Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Tax issues affecting the pharmaceutical industry including international tax. Vaccine excise tax issues and VICP.

LobbyistCovered position, as disclosed
CHRISTOPHER W HATCHER Sch. C, Treasury; Associate Staff, House Rules Committee; LD, Rep. Scott McInnis
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
KARINA LYNCH Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs
CHRISTOPHER E. WILCOX Regional Staff Asst & Staff Asst, Sen. Moynihan; LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings
DANIEL ZIEGLER Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare payment issues and Medicaid issues. Medicare Part D. Drug pricing proposals. Protecting Seniors Through Immunization Act. Policies impacting post pandemic public health emergency Covid-19 vaccine reimbursement and distribution. Pharmacy benefit manager reform proposals.

LobbyistCovered position, as disclosed
ANN MARIE BUERKLE Member of Congress; Commissioner, Acting-Chair at CPSC
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
KARINA LYNCH Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs
CHRISTOPHER E. WILCOX Regional Staff Asst & Staff Asst, Sen. Moynihan; LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings
DANIEL ZIEGLER Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Issues related to pharmaceutical manufacturing and development. Legislative proposals related to WTO TRIPS Waiver.

LobbyistCovered position, as disclosed
CHRISTOPHER W HATCHER Sch. C, Treasury; Associate Staff, House Rules Committee; LD, Rep. Scott McInnis
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
KARINA LYNCH Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs
CHRISTOPHER E. WILCOX Regional Staff Asst & Staff Asst, Sen. Moynihan; LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings
DANIEL ZIEGLER Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Policies impacting post pandemic public health emergency Covid-19 vaccine reimbursement and distribution.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
CHRISTOPHER E. WILCOX Regional Staff Asst & Staff Asst, Sen. Moynihan; LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings
DANIEL ZIEGLER Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Defense DEF

Issues related to pharmaceutical manufacturing and development.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
KARINA LYNCH Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs
CHRISTOPHER E. WILCOX Regional Staff Asst & Staff Asst, Sen. Moynihan; LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings
DANIEL ZIEGLER Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.